Absci (ABSI) Asset Utilization Ratio (2021 - 2026)
Absci (ABSI) posted Asset Utilization Ratio of 0.01 for Q1 2026, down 26.56% sequentially from 0.01 in Q4 2025, and down 58.71% YoY from 0.02 in Q1 2025.
Absci (ABSI) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Absci has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.01 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 58.71% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (down 58.71% YoY) and the FY2025 annual result came in at 0.01, down 38.1% from the prior year.
- Asset Utilization Ratio retreated to 0.01 in Q1 2026 per ABSI's latest filing, from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.03 in Q4 2023 and troughed at 0.0 in Q1 2022.
- A 5-year average of 0.01 and a median of 0.01 in 2025 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio slumped 106.99% in 2022, then jumped 2073.19% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.01 in 2022, then surged by 301.93% to 0.03 in 2023, then fell by 19.86% to 0.02 in 2024, then tumbled by 39.91% to 0.01 in 2025, then slipped by 26.56% to 0.01 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.01, and 0.01 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.02 |